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Abstract Nitric oxide (NO) reductase was purified from
Ralstonia eutropha (formerly Alcaligenes eutrophus) using a
two step chromatographic procedure. Unlike the common NO
reductases, the enzyme consists of a single subunit of 75 kDa
which contains both high-spin and low-spin heme b, but lacks
heme c. One additional iron atom, probably a ferric non-heme
iron, was identified per enzyme molecule. Whereas reduced
cytochrome c was ineffective as electron donor, NO was reduced
at a specific activity of 2.3 Wmol/min per mg of protein in the
presence of 2-methyl-1,4-naphthoquinol.
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1. Introduction
Bacterial nitric oxide (NO) reductases play a crucial role in
the denitri¢cation pathway [1^4]. The enzyme catalyzes the
reduction of the toxic intermediate NO, which is formed by
the dissimilatory nitrite reductase. The product of NO reduc-
tion, nitrous oxide, is ¢nally reduced to dinitrogen by nitrous
oxide reductase. Although there was doubt about NO as an
obligate intermediate [2,5], recent investigations demonstrated
that the absence of NO reductase was lethal for denitrifying
cells [6^9], presumably due to the toxicity of NO. The proto-
type of NO reductase is represented by the NorCB hetero-
dimer, which has been puri¢ed from various denitri¢ers [10^
15]. The NorB subunit was characterized as a membrane-
bound protein which carries two b-type hemes and one non-
heme iron per molecule. Most likely, NO is reduced at a
dinuclear center consisting of a heme b in the high-spin state
and the non-heme iron [16^18]. The DNA sequence of the NO
reductase gene of Pseudomonas stutzeri provided the molecu-
lar basis for the perception that the putative tertiary structure
of NorB resembles that of heme-copper oxidases [3,9]. More-
over, since conserved residues indicate a similar reaction
mechanism, NO reductases are considered to be the evolu-
tionary precursors of heme-copper oxidases [19^21]. Accord-
ing to this view, the heme c containing NorC subunit of NO
reductases would be an analogue of subunit II of heme-copper
oxidases.
In previous investigations, we have shown by sequence
analysis and investigation of mutants that denitrifying cells
of Ralstonia eutropha H16 (formerly Alcaligenes eutrophus,
[22]) contain two NO reductase isoenzymes, designated
NorB and NorZ, which both di¡er from the NorCB proto-
type [7]. NorB and NorZ are clearly homologues of the large
subunits of the known NO reductases, but both proteins carry
a N-terminal extension which has the potential of forming a
large periplasmic loop. A gene with coding capacity for a
NorC-like protein has neither been detected in the vicinity
of norB nor norZ. The apparent absence of a second subunit
raised the question whether the NO reductases from R. eutro-
pha represent a single-component enzyme. If this is the case,
the transfer of reduction equivalents should proceed di¡er-
ently in this type of NO reductase, pointing to a speci¢c
role of the N-terminal extension in the electron transfer proc-
ess. In this work, we have puri¢ed the NorB from R. eutropha
and give evidence that the protein represents a novel type of
quinol oxidase.
2. Materials and methods
2.1. Strains and plasmids
Plasmid pGE423 was used for overexpression of NorB in the strain
R. eutropha HF420 [7], which is a NorB/NorZ negative derivative of
the wild-type H16. For construction of pGE423, a 3.2 kb BsrBI frag-
ment of pCH510 [7], containing the norB gene, was cloned into the
EcoRV-linearized vector pBluescript SK+ (Stratagene), yielding plas-
mid pCH538. A 400 bp fragment was ampli¢ed from pCH538 with
the two primers PNDE: 5P-GGAATTCCATATGGGCTCATATCG-
CAGACT-3P and PBAM: 5P-TTCGAGACGGTCAGCACGCT-3P.
PNDE generates a NdeI site at the start codon of norB. The PCR
fragment was digested with NdeI-BamHI and cloned into the NdeI-
BamHI-linearized vector pET22b+ (Novagen) to give pCH686. The
complete norB gene was restored by cloning a 2.3 kb BamHI-HindIII
fragment from pCH538 into the BamHI-HindIII-linearized plasmid
pCH686, yielding pCH687. A 100 bp fragment was ampli¢ed from
pCH538 with the two primers PECO: 5P-GGCTGGTGCTG-
ATCGGG-3P and PBGL: 5P-GCGCAGATCTCTGCGCGGCGTT-
CAGGCGTCC-3P. PBGL generates a BglII site instead of the TAA
stop codon of norB. The PCR fragment was digested with EcoRI-
BglII and cloned into the EcoRI-BglII-linearized expression vector
pQE60 (Qiagen), yielding pCH624. In this construct, the 3P-norB cod-
ing sequence is extended by six histidine codons (norB-6H). A 190 bp
EcoRI-HindIII fragment from pCH624 was cloned into the EcoRI-
HindIII-linearized plasmid pCH687, which replaced the native 3P-cod-
ing sequence of norB by the modi¢ed norB-6H sequence. From this
plasmid (pCH688), a 2.3 kb XhoI-(Klenow-polished) NdeI fragment
containing the entire norB-6H gene was isolated and cloned into the
NdeI-SnaBI-linearized plasmid pCH591, yielding pCH691. pCH591
carries the promoter of the soluble hydrogenase of R. eutropha. The
detailed construction of pCH591 will be described elsewhere (L. Klei-
hues, O. Lenz, M. Bernhard and B. Friedrich, in preparation). A
2.6 kb HindIII fragment, encompassing the SH promoter region
and the norB-6H gene, was cloned into the HindIII-linearized broad
host range vector pVK101 [23], yielding plasmid pGE423.
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2.2. Puri¢cation of NorB
Strain HF420 bearing plasmid pGE423 was grown at 30‡C in a 70 l
fermenter (Biostad D, Braun, Germany) ¢lled with 50 l mineral salts
medium containing 0.2% (w/v) fructose and 0.2% (w/v) glycerol (FGN
medium). When the culture reached an optical density of 6^7 at 436
nm, aeration was stopped and sodium nitrate was added to a ¢nal
concentration of 10 mM. Cells were harvested by continuous centri-
fugation at 10 000Ug and washed in 50 mM sodium phosphate bu¡er
(pH 7.5). The cell pellet was immediately frozen in liquid nitrogen and
stored at 320‡C. About 5 g of cells (wet weight) was obtained per liter
of medium. All puri¢cation steps were carried out on ice or at 4‡C.
Cells (20 g) were suspended in 10 ml of 50 mM sodium phosphate
bu¡er (pH 7.5) containing 5 ml protease inhibitor cocktail (Sigma).
Solid DNAse I was added and cells were broken by passing them
three times through a French press cell at 1100 psi. The cell debris
was removed by two centrifugation steps for 1 h at 6000Ug. The
supernatant was centrifuged for 1 h at 48 000Ug. The pelleted mem-
branes were resuspended in 50 mM sodium phosphate bu¡er (pH 8.0)
containing 50 mM NaCl, 1 mM 4-(2-aminoethyl)-benzolsulfonyl£uo-
ride to give a ¢nal concentration of 10 mg protein/ml. n-Dodecyl L-D-
maltoside was added to a ¢nal concentration of 1% (w/v) from a 10%
(w/v) stock solution. After 1 h shaking on ice, solubilized components
were separated by centrifugation for 1 h at 48 000Ug.
The clear supernatant was applied to a 10 ml C/10 column (Phar-
macia) packed with 2 ml of a Ni-nitrilotriacetic acid (NTA) silica
matrix (Qiagen), which was previously equilibrated with two column
volumes of 50 mM sodium phosphate bu¡er (pH 8.0) containing
300 mM NaCl, 20 mM imidazole, 0.1% (w/v) n-dodecyl L-D-malto-
side. After washing with the same bu¡er, a step gradient with 50 mM
imidazole was applied. In a ¢nal step, residual proteins were eluted in
a linear gradient from 50 to 200 mM imidazole. Fractions containing
NorB were immediately diluted 10-fold with 50 mM sodium phos-
phate bu¡er (pH 7.0) containing 0.1% (w/v) n-dodecyl L-D-maltoside
and concentrated in Amicon 30K centriprep concentrators to about
1 ml. This step removed most of the imidazole. Contaminating im-
purities were removed by cation exchange chromatography on a PO-
ROS-HS-M column (PerSeptive Biosystems) equilibrated with 50 mM
sodium phosphate bu¡er (pH 7.0), containing 50 mM NaCl, 0.1%
(w/v) n-dodecyl L-D-maltoside, 0.01% (w/v) phosphatidylcholine. NO
reductase was eluted in a bu¡ered linear salt gradient from 50 to
500 mM NaCl. Pooled fractions were concentrated in Amicon 30K
centriprep concentrators to contain 1^2 mg/ml protein. The concen-
trated enzyme solution was stabilized by the addition of 0.1 mM
ethylenediaminetetraacetic acid, 10% (w/v) glycerol and stored at
370‡C.
2.3. Spectroscopy
Optical absorption spectra were measured with a Hitachi U-2000
spectrophotometer. Electron paramagnetic resonance (EPR) spectra
were obtained with a Bruker ESP-300E spectrometer, equipped with
an Oxford helium £ow cryostat. Atomic absorption spectroscopy was
performed on a Perkin-Elmer PE5100/Zeeman spectrometer.
2.4. Enzyme assays
NO reductase activity was assayed at 30‡C as described previously
[7] using a Clark electrode. The reaction mixture (2 ml) contained
50 mM sodium phosphate bu¡er (pH 7.0), 20 mM D-glucose, 10 U
glucose oxidase and 250 U catalase. NO reduction was measured
using 10 Wmol ascorbate plus 0.25 Wmol phenazine methosulfate
(PMS) or N,N,NP,NP-tetramethyl-p-phenylenediamine (TMPD).
NADH-dependent NO reduction was measured using 0.25 Wmol
NADH and 0.35 Wmol of one of the following compounds: 2-meth-
yl-1,4-naphthoquinone, tetramethyl-1,4-benzoquinone, 2,3-dimethoxy-
5-methyl-1,4-benzoquinone and horse heart cytochrome c. Quinols
were formed from the corresponding quinones in the presence of
40 U diaphorase from Chlostridium kluyveri. Cytochrome c was re-
duced in the same way as the quinones. After an incubation period of
5 min, NO-saturated bu¡er (100 nmol NO) was added. The reaction
was started by the addition of NO reductase (15^30 Wg).
2.5. Analytical procedures
Protein concentrations were determined according to Lowry [24].
Cell fractions and puri¢ed protein were analyzed by sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) according to
Laemmli [25] using a 10% polyacrylamide gel. A benchmark protein
standard (Gibco BRL) was used to determine the molecular masses.
Gels were stained for protein with Coomassie brilliant blue G250.
Nitrous oxide was measured by gas chromatography as described
previously [7].
3. Results
3.1. Overexpression of NO reductase in R. eutropha
To facilitate puri¢cation, the C-terminus of NorB was ge-
netically engineered to contain six additional histidine resi-
dues. The modi¢ed gene (norB-6H) was cloned under control
of the promoter of the soluble hydrogenase of R. eutropha and
the recombinant plasmid was transferred into the R. eutropha
mutant HF420 which lacks the NorB and NorZ proteins. For
a controlled expression of norB-6H, the cells were cultivated
on fructose and glycerol, yielding a diauxic growth. The pro-
moter of the hydrogenase is derepressed during energy limi-
tation on poor carbon sources like glycerol [26]. However,
preliminary experiments indicated that NorB was produced
as an inactive protein under these conditions. Therefore, the
culture was shifted to denitrifying conditions after fructose
was exhausted. The expression of active NO reductase was
monitored by determination of the reaction product, nitrous
oxide.
3.2. Puri¢cation of NO reductase
A summary of the puri¢cation of NO reductase is given in
Table 1. NO reductase was solubilized from the membrane
fraction in the presence of the detergent, n-dodecyl L-D-malto-
side. About 80% pure protein was obtained after immobilized-
metal ion a⁄nity chromatography on the Ni-NTA column.
The NO reductase eluted as a single peak above 150 mM
imidazole, as monitored by the absorption at 415 nm. Since
the protein precipitated slowly in the presence of high concen-
trations of imidazole, the eluate was diluted 10-fold and sub-
sequently concentrated to a ¢nal concentration of 2 mg/ml.
Contaminating proteins were removed by cation exchange
chromatography. A minor fraction of NO reductase and
most of the contaminating proteins did not bind to the col-
umn. Bound NO reductase was eluted in a linear salt gradient
above 200 mM NaCl. Since the protein tends to smear on the
Table 1
Puri¢cation of NorB
Puri¢cation step Total protein (mg) Speci¢c activitya (nmol NO/mg/min) Yield (%)
Membranes 550 507 100
Membranesb 290 510 53
Silica-NTA 3.1 1 950 2.2
POROS-HS 1.9 2 790 1.9
aMeasured with ascorbate+PMS as electron donor.
bAfter solubilization in 1% n-dodecyl L-D-maltoside for 2 h.
FEBS 22753 11-10-99
R. Cramm et al./FEBS Letters 460 (1999) 6^10 7
column, fractions were checked for purity by SDS-PAGE be-
fore pooling.
Puri¢ed NO reductase was homogenous on SDS-PAGE,
showing a single band with an apparent molecular mass of
75 kDa (Fig. 1). The discrepancy of this size and the molec-
ular mass of 84.5 kDa, as calculated from the amino acid
sequence [7], may be due to the hydrophobicity of the protein.
Similar observations are reported for the large subunit of the
NO reductases from other denitri¢ers [13^15,17].
3.3. Spectroscopic analysis
Fig. 2A shows the optical spectra of the oxidized (as iso-
lated) and the reduced (dithionite) NO reductase. The maxima
in the Soret region at 414 nm in the oxidized state and at
423 nm in the reduced state are typical for a hemoprotein.
The oxidized enzyme displayed a broad peak with a maximum
at 534 nm and a shoulder at around 565 nm. The sharpening
and increase in intensity upon reduction, with peaks at 527
and 557 nm in the L- and K-band region, suggest the presence
of low-spin heme b. An additional weak signal was observed
at approximately 599 nm in the reduced enzyme. Nevertheless,
a clear decrease in absorbance at 580 nm upon reduction is
visible in the reduced minus oxidized di¡erence spectrum (Fig.
2B). A similar decrease in absorbance has been observed with
all NO reductases puri¢ed so far and was assigned to a charge
transfer transition of high-spin heme b [13]. The lack of a
signal at around 551 nm in the reduced enzyme suggests
that heme c is absent from the NO reductase of R. eutropha.
The EPR spectrum of the NO reductase, as isolated, shows
typical features of a protein containing high-spin and low-spin
hemes (Fig. 3). A signal at g = 6.0 was weak at 10 K (A) but
clearly visible when lowering the temperature to 4 K (B). This
signal is most likely due to high-spin heme iron. A signal at
g = 4.3 could be derived from adventitious iron. The g = 2.01
signal may be due to a non-metallic radical, however, such a
signal may also be derived from a non-heme high-spin ferric
iron. Two out of the four remaining signals can be ascribed to
a low-spin heme, most likely with parameters gz = 2.96,
gy = 2.28. Another broad and very weak signal at around
g = 1.4 (data not shown) was observed at a high instrument
sensitivity, which may represent the gx component of a low-
spin heme. The origin of the signals at g = 2.55 and at g = 2.07
is uncertain. A signal at g = 2.5 has been assigned to the gz
component of a low-spin species in the cytochrome bd ubiq-
uinol oxidase from Escherichia coli [27].
Atomic absorption spectroscopy showed the presence of 2.8
Fe atoms per protein molecule. Copper was detected at a
concentration of 0.2 atoms per protein molecule. Based on
the spectroscopic properties, one can assume that the enzyme
contains one high-spin heme and at least one low-spin heme
per molecule. The low-spin species represents most likely a
b-type heme, since neither a heme c signal was obtained in
the optical spectra nor the amino acid sequence of NorB
shows an appropriate sequence for binding of heme c. Fur-
thermore, heme staining of the puri¢ed protein in SDS-PAGE
(not shown) gave no evidence for covalently bound heme.
3.4. Kinetic properties
Table 2 shows the activity of puri¢ed NorB in the presence
of di¡erent electron donors. Ascorbate-reduced PMS turned
out to be the most e¡ective electron donor for this enzyme.
However, the speci¢c activity was 2^10-fold lower than the
PMS-dependent activities reported for the NO reductases of
P. stutzeri and Paracoccus denitri¢cans [13,14]. When TMPD
was used instead of PMS, the activity dropped by one order
of magnitude. TMPD was used successfully with the NO re-
ductase from P. denitri¢cans [17], but was reported to be in-
e¡ective with the enzyme from P. stutzeri [14]. Interestingly,
the NO reductase of R. eutropha showed also quinol oxidase
activity. In particular, reduced menadione led to an activity
which is comparable to that obtained with reduced PMS. The
activities with the quinols appeared to be mainly a function of
Fig. 1. SDS-PAGE of puri¢ed NO reductase. Lane 1: standard pro-
teins, the molecular masses (kDa) are shown on the left side. Lane
2: 2 Wg of puri¢ed NO reductase.
Fig. 2. Optical absorption spectra of puri¢ed NO reductase. A: Ab-
solute spectra of the oxidized and dithionite-reduced (dashed line)
states. The inset shows a magni¢cation of the K- and L-band region.
B: Dithionite-reduced minus oxidized di¡erence spectrum.
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their redox potentials with E0P=31 mV (menadiol), +35 mV
(duroquinol) and +162 mV (Q0H2) [28]. Quinol oxidation was
not signi¢cantly decreased in the presence of up to 1 mM 2-
heptyl-4-hydroxyquinoline-N-oxide (HOQNO). HOQNO, an
inhibitor of electron transfer, acts at quinone-binding sites
[29,30]. No activity was observed when either diaphorase or
NADH was omitted from the reaction mixture. Compara-
tively high activities were obtained, however, in the presence
of NADH and diaphorase when no quinone was added. Ap-
parently, the NO reductase acts as an electron acceptor of
diaphorase under these conditions. The reaction was blocked
in the presence of horse heart cytochrome c, which is reduced
by diaphorase but which is not oxidized by the NO reductase.
Thus, unlike the common NorCB-type NO reductases, the
physiological electron donor for the enzyme from R. eutropha
is most probably a quinol, but not a cytochrome c.
4. Discussion
Analysis of the gene region encoding NorB of R. eutropha
showed that the protein, although extended by a N-terminal
domain, is homologous to the catalytic subunits of common
NO reductases [7]. In particular, all residues which are con-
sidered as putative ligands of the prosthetic groups [20,21] are
conserved. Therefore, the enzyme from R. eutropha should
reveal spectroscopic properties similar to those of the large
subunit of common NO reductases. Indeed, optical spectros-
copy con¢rmed the presence of heme b and the absence of
heme c, which is a constituent of the small subunit of common
NO reductases. However, the EPR data available for the lat-
ter group of enzymes have been interpreted controversially.
Whereas the low-spin species with parameters around
gxyz = 1.3, 2.3, 2.9 has been assigned to heme c in the NO
reductases from P. denitri¢cans and Paracoccus halodenitri¢-
cans [13,15], an equivalent signal was assigned to heme b in
the NO reductases from P. stutzeri [16]. Since a similar signal
is also derived from the NO reductase of R. eutropha, which
does not contain heme c, our data support the latter assign-
ment. All NO reductases puri¢ed so far contain additional
iron not derived from heme. The signals around g = 2.00
and/or g = 4.3 have been assigned to this non-heme iron
[13,15]. However, in preparations from P. stutzeri [16] and
P. denitri¢cans [17], this signal was absent. Thus, the
g = 2.01 signal observed with the NO reductase from R. eutro-
pha may result from an additional component. Although a
signal in the g = 2 region may re£ect a contamination by a
[3Fe4S] cluster [16,31], atom absorption spectroscopy of NorB
indicated no elevated iron content.
The most intriguing feature of the NO reductase of R. eu-
tropha is the presence of a N-terminal extension of approxi-
mately 280 amino acids. Obviously, the ability for quinol ox-
idation is a property of this extra domain. Indeed, a mutant
containing a NO reductase which is devoid of this domain is
unable to denitrify (R. Cramm and B. Friedrich, unpublished
data). Since NO reductases are considered as distant relatives
of both quinol oxidases and cytochrome c oxidases
[16,20,21,32], the existence of a quinol-oxidizing NO reductase
seems to be not surprising. Nevertheless, no homology is ap-
parent between the extension of NorB and the quinol-oxidiz-
ing subunit of terminal oxidases. Thus, the NO reductase
from R. eutropha may represent a novel type of quinol-oxidiz-
ing enzyme.
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Fig. 3. X-band EPR spectra of puri¢ed NO reductase as isolated.
Experimental conditions: frequency 9.650 GHz, modulation fre-
quency 100 kHz, modulation amplitude 1.6 mT, time constant
327 ms, microwave power 40 mW (A) or 5 mW (B), temperature
11 K (A) or 4.1 K (B).
Table 2
NO reduction of NorB with various electron donors
Electron donor Speci¢c activity (nmol NO/mg/min)
NADH 1 530
NADH+2-methyl-1,4-naphthoquinone (menadione) 2 270
NADH+tetramethyl-1,4-benzoquinone (duroquinone) 780
NADH+2,3-dimethoxy-5-methyl-1,4-benzoquinone (Q0) 160
NADH+cytochrome c (horse heart) 6 1
TMPD+ascorbate 220
PMS+ascorbate 2790
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